四川(chuan)(chuan)美(mei)(mei)(mei)大(da)(da)康(kang)(kang)(kang)藥業(ye)(ye)股份有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)，由(you)四川(chuan)(chuan)藍(lan)劍投(tou)資管理有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)等五(wu)家公(gong)(gong)(gong)(gong)司(si)共同(tong)投(tou)資興辦。其麾下擁有(you)七個子(zi)公(gong)(gong)(gong)(gong)司(si)，地處(chu)北京、成都和什邡、綿竹市，分別是(shi)：四川(chuan)(chuan)美(mei)(mei)(mei)大(da)(da)康(kang)(kang)(kang)佳(jia)樂藥業(ye)(ye)有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、四川(chuan)(chuan)美(mei)(mei)(mei)大(da)(da)康(kang)(kang)(kang)華康(kang)(kang)(kang)藥業(ye)(ye)有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、四川(chuan)(chuan)美(mei)(mei)(mei)大(da)(da)康(kang)(kang)(kang)仁愛(ai)醫藥有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、四川(chuan)(chuan)美(mei)(mei)(mei)大(da)(da)康(kang)(kang)(kang)仁愛(ai)大(da)(da)藥房連鎖有(you)限(xian)(xian)公(gong)(gong)(gong)(gong)司(si)、北京美(mei)(mei)(mei)大(da)(da)康(kang)(kang)(kang)創業(ye)(ye)醫藥科技開發有(you)限(xian)(xian)責(ze)任(ren)公(gong)(gong)(gong)(gong)司(si)、四川(chuan)(chuan)美(mei)(mei)(mei)大(da)(da)康(kang)(kang)(kang)中(zhong)藥飲片有(you)限(xian)(xian)責(ze)任(ren)公(gong)(gong)(gong)(gong)司(si)、四川(chuan)(chuan)美(mei)(mei)(mei)大(da)(da)康(kang)(kang)(kang)中(zhong)藥材(cai)種植(zhi)有(you)限(xian)(xian)責(ze)任(ren)公(gong)(gong)(gong)(gong)司(si)。
四(si)川美大康藥(yao)(yao)(yao)(yao)業(ye)股份有(you)限(xian)公(gong)司目前(qian)是一(yi)家(jia)集(ji)現(xian)(xian)代(dai)(dai)化(hua)中(zhong)(zhong)藥(yao)(yao)(yao)(yao)、生物醫藥(yao)(yao)(yao)(yao)、化(hua)學合成(cheng)藥(yao)(yao)(yao)(yao)、原料藥(yao)(yao)(yao)(yao)、營養保健(jian)食品為一(yi)體(ti)，具有(you)獨立研(yan)發、生產(chan)、經營能力(li)的(de)現(xian)(xian)代(dai)(dai)化(hua)制藥(yao)(yao)(yao)(yao)企(qi)業(ye)集(ji)團(tuan)，并形(xing)成(cheng)以(yi)藥(yao)(yao)(yao)(yao)材種植、飲片生產(chan)、及運用在線(xian)檢測技術(shu)的(de)現(xian)(xian)代(dai)(dai)中(zhong)(zhong)藥(yao)(yao)(yao)(yao)數字化(hua)提取為中(zhong)(zhong)藥(yao)(yao)(yao)(yao)原料體(ti)系(xi)，以(yi)中(zhong)(zhong)藥(yao)(yao)(yao)(yao)現(xian)(xian)代(dai)(dai)化(hua)制劑(ji)技術(shu)為中(zhong)(zhong)心的(de)構(gou)建成(cheng)現(xian)(xian)代(dai)(dai)中(zhong)(zhong)藥(yao)(yao)(yao)(yao)產(chan)業(ye)鏈。
四(si)川(chuan)美大(da)(da)康(kang)藥(yao)業(ye)股(gu)(gu)份有限公(gong)司(si)為了可持續發(fa)展(zhan)一直堅持技術(shu)(shu)創(chuang)新(xin)，從行業(ye)結構特點(dian)和核(he)心能力(li)較佳匹配的(de)角度，把三個(ge)實體企業(ye)的(de)發(fa)展(zhan)方向按(an)技術(shu)(shu)創(chuang)新(xin)的(de)類型分別(bie)進行不同的(de)戰略(lve)定位，即美大(da)(da)康(kang)股(gu)(gu)份公(gong)司(si)以(yi)(yi)(yi)中藥(yao)現代(dai)化(hua)為發(fa)展(zhan)方向，在目前(qian)以(yi)(yi)(yi)抗炎保肝的(de)產品作為核(he)心，美大(da)(da)康(kang)佳樂(le)公(gong)司(si)以(yi)(yi)(yi)做細做精輸液為發(fa)展(zhan)方向，以(yi)(yi)(yi)轉化(hua)糖、抗腫瘤的(de)產品為核(he)心，美大(da)(da)康(kang)華康(kang)以(yi)(yi)(yi)高起(qi)點(dian)化(hua)學合成(cheng)藥(yao)為發(fa)展(zhan)方向，以(yi)(yi)(yi)抗真菌(jun)領(ling)域(yu)的(de)產品為核(he)心。
以三個實體為(wei)基(ji)礎，調整(zheng)資源配置和能力(li)培養的(de)重(zhong)點(dian)，建(jian)立了公司的(de)技術(shu)中心。它既是公司的(de)基(ji)礎研究和新藥(yao)開發(fa)中心，又是培養制藥(yao)領域高級人(ren)才(cai)的(de)搖籃，肩負(fu)企業技術(shu)開發(fa)和人(ren)才(cai)培養“孵化器”的(de)作用，主要負(fu)責(ze)新產(chan)品(pin)的(de)開發(fa)。產(chan)業化研究平臺(tai)與研發(fa)平臺(tai)的(de)密切結合，可促使基(ji)礎科研成果(guo)盡快地(di)轉(zhuan)化為(wei)生產(chan)力(li)，實現生產(chan)效益(yi)，進一步提高了產(chan)品(pin)的(de)品(pin)質和效益(yi)。
目(mu)前四(si)川美大康藥(yao)業股份(fen)有(you)限公(gong)司擁有(you)粉(fen)針劑(ji)、大容(rong)量注射劑(ji)、小容(rong)量注射劑(ji)、片劑(ji)、膠囊劑(ji)、顆粒(li)劑(ji)、合劑(ji)(含口(kou)服液)、滴眼劑(ji)、搽劑(ji)、原(yuan)料藥(yao)等十(shi)種(zhong)劑(ji)型(xing)304個(ge)品規。擁有(you)5個(ge)優質品種(zhong)和資源(yuan)。目(mu)前公(gong)司還有(you)29個(ge)在研產品，新藥(yao)糖耐康進入(ru)三(san)期臨(lin)床、地黃進入(ru)四(si)期臨(lin)床。
